Antidepressant DTC Ads Must Disclose New Risk Information Within 30 Days
This article was originally published in The Pink Sheet Daily
Executive Summary
Antidepressant manufacturers have 30 days to bring their direct-to consumer ads into compliance following FDA's approval of a "black box" class warning